Essential Thrombocythemia. Reply

Ayalew Tefferi; Animesh Pardanani

doi:10.1056/NEJMc1917586

Essential Thrombocythemia. Reply

Hematology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e21
Journal	The New England journal of medicine
Volume	382
Issue number	12
DOIs	https://doi.org/10.1056/NEJMc1917586
State	Published - Mar 19 2020

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc1917586

Cite this

@article{22b4dc0d337a405b9d68523d5b6ce6d4,

title = "Essential Thrombocythemia. Reply",

author = "Ayalew Tefferi and Animesh Pardanani",

year = "2020",

month = mar,

day = "19",

doi = "10.1056/NEJMc1917586",

language = "English (US)",

volume = "382",

pages = "e21",

journal = "The New England journal of medicine",

issn = "1533-4406",

publisher = "Massachussetts Medical Society",

number = "12",

}

TY - JOUR

T1 - Essential Thrombocythemia. Reply

AU - Tefferi, Ayalew

AU - Pardanani, Animesh

PY - 2020/3/19

Y1 - 2020/3/19

UR - http://www.scopus.com/inward/record.url?scp=85082002828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082002828&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1917586

DO - 10.1056/NEJMc1917586

M3 - Letter

C2 - 32187488

AN - SCOPUS:85082002828

SN - 1533-4406

VL - 382

SP - e21

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 12

ER -

Essential Thrombocythemia. Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this